Systematic review: recurrent autoimmune liver diseases after liver transplantation
ConclusionsRecommendations based on grade A level of evidence are lacking. The need for further study and management includes active immunosuppression before liver transplantation and steroid use after liver transplantation in autoimmune hepatitis; selective immunosuppression with ciclosporin and preventive ursodeoxycholic acid treatment for primary biliary cholangitis; and improved control of inflammatory bowel disease or even colectomy in primary sclerosing cholangitis.
Source: Alimentary Pharmacology and Therapeutics - Category: Drugs & Pharmacology Authors: A. J. Montano ‐Loza, R. A. Bhanji, S. Wasilenko, A. L. Mason Tags: Systematic Review Source Type: research
More News: Autoimmune Disease | Cholestasis | Cirrhosis | Colectomy | Drugs & Pharmacology | Hepatitis | Inflammatory Bowel Disease | Liver | Liver Disease | Liver Transplant | Prograf | Study | Tacrolimus | Transplants | Ulcerative Colitis | Urology & Nephrology